Patents by Inventor MICHAEL WAN CHO

MICHAEL WAN CHO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOGENIC AND VACCINE COMPOSITIONS AGAINST SARS-CoV-2
    Publication number: 20220323574
    Abstract: Disclosed herein are immunogenic and/or vaccine compositions and methods for treating or preventing Severe Acute Respiratory Syndrome (SARS). The compositions and methods include an immunogenic portion of the receptor-binding domain (RBD) of the SARS-CoV-2-2 (COVID-19) spike protein. In at least particular cases, a mutated version of a portion of the RBD is utilized, such as a deglycosylated, or amino acid substituted mutant of the spike protein.
    Type: Application
    Filed: June 1, 2022
    Publication date: October 13, 2022
    Inventor: MICHAEL WAN CHO
  • Immunogenic and vaccine compositions against SARS-CoV-2
    Patent number: 11376320
    Abstract: Disclosed herein are immunogenic and/or vaccine compositions and methods for treating or preventing Severe acute respiratory syndrome (SARS). The compositions and methods include an immunogenic portion of the receptor-binding domain (RBD) of the SARS-CoV-2-2 (COVID-19) spike protein. In at least particular cases, a mutated version of a portion of the RBD is utilized, such as a deglycosylated, or amino acid substituted mutant of the spike protein.
    Type: Grant
    Filed: March 4, 2021
    Date of Patent: July 5, 2022
    Assignee: Iowa State University Research Foundation, Inc.
    Inventor: Michael Wan Cho
  • IMMUNOGENIC AND VACCINE COMPOSITIONS AGAINST SARS-CoV-2
    Publication number: 20210275665
    Abstract: Disclosed herein are immunogenic and/or vaccine compositions and methods for treating or preventing Severe acute respiratory syndrome (SARS). The compositions and methods include an immunogenic portion of the receptor-binding domain (RBD) of the SARS-CoV-2-2 (COVID-19) spike protein. In at least particular cases, a mutated version of a portion of the RBD is utilized, such as a deglycosylated, or amino acid substituted mutant of the spike protein.
    Type: Application
    Filed: March 4, 2021
    Publication date: September 9, 2021
    Inventor: MICHAEL WAN CHO